Peptide receptor pharmacology as a research subject

The GLP-1, GIP, and glucagon receptors are class B G protein-coupled receptors that have been the subject of extensive published structural biology and pharmacology research over the past decade. Peptide agonists engineered for these receptors — including single-receptor, dual-receptor, and triple-receptor agonist designs — are commonly used in laboratory settings to study receptor binding affinity, signal transduction, and structure-activity relationships.

What the published literature covers

Structural biology work, including cryo-electron microscopy studies, has characterized how these peptide agonists engage their receptor binding pockets and initiate downstream signaling. Analytical chemistry literature has separately examined the proteolytic stability, formulation behavior, and receptor-selectivity profiles of this peptide class, comparing single, dual, and triple receptor agonist designs.

Research applications

Laboratories working with this peptide class typically focus on receptor-binding assay development, structure-activity relationship (SAR) mapping across peptide backbone modifications, comparative receptor-selectivity studies between analog designs, and analytical method development — including HPLC and mass spectrometry — for peptide identity and purity confirmation.